ATE401900T1 - Verwendung von polyethylenglycol ( peg ) zur herstellung eines medikamentes zur behandlung von verstopfung - Google Patents
Verwendung von polyethylenglycol ( peg ) zur herstellung eines medikamentes zur behandlung von verstopfungInfo
- Publication number
- ATE401900T1 ATE401900T1 AT01975466T AT01975466T ATE401900T1 AT E401900 T1 ATE401900 T1 AT E401900T1 AT 01975466 T AT01975466 T AT 01975466T AT 01975466 T AT01975466 T AT 01975466T AT E401900 T1 ATE401900 T1 AT E401900T1
- Authority
- AT
- Austria
- Prior art keywords
- peg
- polyethylene glycol
- medication
- constitution
- treatment
- Prior art date
Links
- 239000002202 Polyethylene glycol Substances 0.000 title abstract 5
- 229920001223 polyethylene glycol Polymers 0.000 title abstract 5
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 206010010774 Constipation Diseases 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 230000003871 intestinal function Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/675,105 US6645481B1 (en) | 2000-09-28 | 2000-09-28 | Method of achieving overnight laxation and control of bowel function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE401900T1 true ATE401900T1 (de) | 2008-08-15 |
Family
ID=24709076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01975466T ATE401900T1 (de) | 2000-09-28 | 2001-09-27 | Verwendung von polyethylenglycol ( peg ) zur herstellung eines medikamentes zur behandlung von verstopfung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6645481B1 (de) |
| EP (1) | EP1326592B1 (de) |
| AT (1) | ATE401900T1 (de) |
| AU (1) | AU2001294790A1 (de) |
| CA (1) | CA2423746A1 (de) |
| CY (1) | CY1110052T1 (de) |
| DE (1) | DE60135001D1 (de) |
| DK (1) | DK1326592T3 (de) |
| ES (1) | ES2310190T3 (de) |
| PT (1) | PT1326592E (de) |
| SI (1) | SI1326592T1 (de) |
| WO (1) | WO2002026222A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7291324B2 (en) * | 2002-10-22 | 2007-11-06 | Braintree Laboratories Inc. | Method of bowel cleansing |
| EP1684772A1 (de) * | 2003-11-17 | 2006-08-02 | Braintree Laboratories, Inc. | Therapeutisches peg-lösungskonzentrat |
| US7687075B2 (en) | 2003-11-19 | 2010-03-30 | Salix Pharmaceuticals, Ltd. | Colonic purgative composition with soluble binding agent |
| US7256202B2 (en) * | 2003-12-31 | 2007-08-14 | Halow George M | Composition and method for treatment of hepatic encephalopathy |
| US20050244368A1 (en) * | 2004-04-29 | 2005-11-03 | Pashankar Dinesh S | Pre-endoscopic use of polyethylene glycol compositions |
| WO2006118562A1 (en) * | 2005-04-29 | 2006-11-09 | Inkine Pharmaceutical Company, Inc. | Purgative composition and uses thereof |
| US20060247180A1 (en) * | 2005-04-29 | 2006-11-02 | Bergey James L | Purgative composition and uses thereof |
| US7495063B2 (en) * | 2006-02-03 | 2009-02-24 | Dow Global Technologies Inc. | Reduced oligomer concentration in high purity polyalkylene glycols |
| EP3563838A1 (de) | 2013-03-15 | 2019-11-06 | Braintree Laboratories, Inc. | Doppelt verwendbare orale tabletten einer pharmazeutischen zusammensetzung aus sulfatsalzen und verfahren zur verwendung davon |
| JP2017514521A (ja) | 2014-04-29 | 2017-06-08 | コロナリーコンセプツ エルエルシー | 電解質補給物をもたらすための食品、システム、方法、及びキット |
| KR102091852B1 (ko) | 2015-03-02 | 2020-03-23 | 코로나리콘셉츠 엘엘씨 | Peg 대사산물 및 peg 분해 생성물 검정을 위한 화합물 및 방법 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5710183A (en) | 1995-07-14 | 1998-01-20 | Halow; George M. | Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent |
| US6048901A (en) * | 1999-04-20 | 2000-04-11 | Braintree Laboratories, Inc. | Method of reducing intestinal gas, cramping and anorectal irritation |
-
2000
- 2000-09-28 US US09/675,105 patent/US6645481B1/en not_active Expired - Lifetime
-
2001
- 2001-09-27 EP EP01975466A patent/EP1326592B1/de not_active Expired - Lifetime
- 2001-09-27 CA CA002423746A patent/CA2423746A1/en not_active Withdrawn
- 2001-09-27 DE DE60135001T patent/DE60135001D1/de not_active Expired - Lifetime
- 2001-09-27 AU AU2001294790A patent/AU2001294790A1/en not_active Abandoned
- 2001-09-27 SI SI200130868T patent/SI1326592T1/sl unknown
- 2001-09-27 DK DK01975466T patent/DK1326592T3/da active
- 2001-09-27 AT AT01975466T patent/ATE401900T1/de active
- 2001-09-27 ES ES01975466T patent/ES2310190T3/es not_active Expired - Lifetime
- 2001-09-27 WO PCT/US2001/030227 patent/WO2002026222A2/en not_active Ceased
- 2001-09-27 PT PT01975466T patent/PT1326592E/pt unknown
-
2008
- 2008-10-16 CY CY20081101155T patent/CY1110052T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002026222A8 (en) | 2002-06-27 |
| SI1326592T1 (sl) | 2009-02-28 |
| US6645481B1 (en) | 2003-11-11 |
| EP1326592B1 (de) | 2008-07-23 |
| AU2001294790A1 (en) | 2002-04-08 |
| EP1326592A1 (de) | 2003-07-16 |
| CA2423746A1 (en) | 2002-04-04 |
| DK1326592T3 (da) | 2008-11-10 |
| WO2002026222A2 (en) | 2002-04-04 |
| CY1110052T1 (el) | 2015-01-14 |
| PT1326592E (pt) | 2008-10-20 |
| ES2310190T3 (es) | 2009-01-01 |
| DE60135001D1 (de) | 2008-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110052T1 (el) | Η χρηση της πολυαιθυλενογλυκολης (peg) για την κατασκευη φαρμακου για τη θεραπεια της δυσκοιλιοτητας | |
| MX9704059A (es) | Derivado de amidinonaftilo novedoso o sal del mismo. | |
| BE2015C026I2 (en) | 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens | |
| MXPA04001328A (es) | Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso. | |
| DE69737834D1 (de) | Folienzusammensetzungen aus Polymerisat zur Herstellung von Kapseln | |
| HUT77944A (hu) | Ondansetront tartalmazó, orálisan beadható, folyékony gyógyszerkészítmény | |
| DE59410052D1 (de) | Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids | |
| NZ516349A (en) | Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease | |
| ATE243196T1 (de) | Piperidine und pyrrolidine | |
| BR0113751A (pt) | Composições cosméticas e farmacêuticas e seus empregos | |
| ATE495187T1 (de) | Dalda-analoge und ihre verwendung | |
| EP1048297A3 (de) | Verwendung von Polyethylenglykol zur Verminderung von Darmgasen, Krämpfen und Anorektalereizung | |
| DE50014532D1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| ATE259234T1 (de) | Verwendung von phospholipiden zur herstellung eines arzneimittels zur vorbeugung von adhäsionen | |
| SE0003476D0 (sv) | Compounds | |
| TR199701121T1 (xx) | Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri. | |
| YU28002A (sh) | Farmaceutska kompozicija koja sadrži ciklesonid za primenu na sluzokoži | |
| PT1214061E (pt) | Nova utilizacao de docetaxel para o tratamento do carcinoma hepatocelular | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| MA22343A1 (fr) | Compositions type massepain, contenant du psyllium | |
| ATE555787T1 (de) | Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies | |
| BG104958A (bg) | Стабилни състави, съдържащи левосимендан и алгинова киселина | |
| DE59408645D1 (de) | Lactulose-pastillen | |
| UY27376A1 (es) | Formulación de medicamento que contiene un antagonista de ltb4 | |
| HRP20040165B1 (hr) | Upotreba citaloprama u liječenju povišenog krvnogtlaka |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1326592 Country of ref document: EP |